Find clinical trials for Ovarian Cancer in Boston, MA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Boston, MA, USA:
that can be safely and tolerably administered in recurrent ovarian cancer.The names of the study drugs involved in this study are:*...
Phase 1
Boston, Massachusetts, United States and 2 other locations
(CIML) natural killer (NK) cell therapy in recurrent, high grade ovarian cancer (HGOC).Names of the study therapies involved in thi...
Phase 1
Boston, Massachusetts, United States and 1 other location
The goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated w...
Phase 2
Boston, Massachusetts, United States and 25 other locations
in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...
Phase 3
Boston, Massachusetts, United States and 204 other locations
The goal of this clinical trial is to learn if the experimental antibody COM701 delays the progression of ovarian cancer in partici ...
Phase 1, Phase 2
Boston, Massachusetts, United States and 27 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Boston, Massachusetts, United States and 126 other locations
in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian...
Phase 2
Boston, Massachusetts, United States and 52 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Boston, Massachusetts, United States and 70 other locations
This research study is evaluating three drugs called Nivolumab, Bevacizumab, and Rucaparib as a possible treatment for relapsed Relapsed Ovarian...
Phase 2
Boston, Massachusetts, United States and 2 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Boston, Massachusetts, United States and 176 other locations
Clinical trials
Research sites
Resources
Legal